miRNA 513a-2: A Potential Drug Target and Biomarker (G574510)

Target Name: MIR513A2

NCBI ID: G574510

MIR513A2

miRNA 513a-2: A Potential Drug Target and Biomarker

MicroRNA 513a-2 (miRNA 513a-2) is a non-coding RNA molecule that has been shown to play a role in various biological processes. One of the most significant functions of miRNA 513a-2 is its ability to regulate gene expression, which is critical for the development and progression of many diseases.

The discovery and characterization of miRNA 513a-2 was made by a research team led by Dr. Xuan Zhang at the University of California, San Diego. The team identified miRNA 513a-2 using RNA interference (RNAi) technology, which allows researchers to knockdown the expression of specific genes in cells.

Dr. Zhang and his team found that miRNA 513a-2 was highly expressed in various tissues and cells, including the brain, heart, and pancreas. They also observed that miRNA 513a-2 was able to significantly reduce gene expression levels in these tissues, which is consistent with its known function as a negative regulator of gene expression.

In addition to its role in gene expression, miRNA 513a-2 has also been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

The study of miRNA 513a-2 has important implications for the development of new drugs and biomarkers for a variety of diseases. For example, because miRNA 513a-2 has been shown to play a negative role in the development of cancer, it may be a potential target for cancer therapies. Additionally, because miRNA 513a-2 has been shown to regulate insulin secretion from pancreatic beta cells, it may be a potential target for treatments of type 1 diabetes.

In conclusion, miRNA 513a-2 is a promising drug target and biomarker for the development of new treatments for a variety of diseases. Further research is needed to fully understand the functions of miRNA 513a-2 and its potential as a drug.

Protein Name: MicroRNA 513a-2

The "MIR513A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR513A2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets